Benzil

Benzil

SCHEMBL2258707

O=C(C(=O)c1ccccc1)c1ccccc1.[PbH2]

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 12/20 0.93
▸ CES1 P23141 12/20 0.93
▸ TSHR P16473 2/20 0.61
▸ DAO P14920 1/20 0.61
▸ NAPRT Q6XQN6 1/20 0.61
▸ ALDH1A1 P00352 1/20 0.61
▸ RAB9A P51151 1/20 0.58
▸ CYP3A4 P08684 2/20 0.55
▸ MAPT P10636 2/20 0.55
▸ TDP1 Q9NUW8 2/20 0.55
▸ CA2 P00918 2/20 0.55
▸ CA4 P22748 2/20 0.55
▸ POLB P06746 1/20 0.55
▸ PARP1 P09874 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ RECQL P46063 1/20 0.55
▸ BLM P54132 1/20 0.55
▸ PMP22 Q01453 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzil SCHEMBL7142843 0.97 CES2 (1.00) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL9517636 0.97 CES2 (1.00) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL28475956 0.97 CES2 (1.00) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL66 0.97 CES2 (1.00) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL2156589 0.97 CES2 (1.00) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL6031169 0.93 CES2 (0.93) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL2092789 0.93 CES2 (0.93) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL11427786 0.93 CES2 (0.93) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL2227748 0.93 CES2 (0.93) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL11516323 0.93 CES2 (0.93) CES2CES1TSHRDAONAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994169-B2 By condensation with a 1,2 carbonyl compound such as glyxoal to form ring and then reduction to form the tetrahydropyrido[3,4-b]pyrazine; acylation catalyst for esterification of ethynylcyclohexanol with acetic anhydride BAYER MATERIALSCIENCE AG (DE) 2011-08-09 — — US disclosed
US-20080176747-A1 3,4-diaminopyridine derivatives BAYER MATERIALSCIENCE AG (DE) 2008-07-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176747-A1 3,4-diaminopyridine derivatives DPYD, QDPR, DDC CES2 2211/4885CES1 4725/4885TSHR 4361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback